Second person dies in the last Ebola outbreak in the Democratic Republic of the Congo

ON The second person died in the 12th registered Ebola outbreak in the Democratic Republic of the Congo. The World Health Organization and the country’s Ministry of Health announced today (February 11). The 60-year-old woman had ties to another woman who was married to a survivor of a previous outbreak in the Democratic Republic of the Congo who had died a few days earlier, according to Reuters.

The cases occurred in the country’s North Kivu province, where the World Health Organization (WHO) reported an earlier outbreak of the disease last summer. Up until that outbreak in the Democratic Republic of the Congo in 2018, there had been more than 2,000 deaths by then.

See “Two New Ebola Deaths In The Democratic Republic Of The Congo Outbreak”

The first person to die in the most recent outbreak was a 42-year-old woman who likely contracted the disease sexually from her husband, according to an official interviewed by WHO The Washington Post. “The evidence has grown over the years that the virus can be found in semen for three, even nine months, or in some cases even two years,” says Ngoy Nsenga post. “Part of our advice to survivors is teaching them that sexual activity is at risk of transmission and even doing tests on their sperm to see if they are free of the virus.”

See “Antibody Spike Months After Ebola Infection Surprisingly Frequently”

The 42-year-old woman visited at least three health centers in the last week of January and the first week of February. This emerges from a statement by the WHO. “By February 8, 2021, a total of 117 contacts had been identified that are currently being followed up,” the statement said. “Investigations and response activities are ongoing.”

There are currently two government-approved vaccines for the prevention of Ebola: Merck’s Ervebo and a combined vaccine developed by the Janssen subsidiary of Johnson & Johnson. According to the WHO, there are two therapeutics for Regeneron’s antibody cocktail REGN-EB3 (Inmazeb) and the monoclonal antibody Ansuvimab (Ebanga) from Ridgeback Therapeutics for up to 400 patients in the country.

See “Ebola vaccine approved for use in Europe”



Source link

Posted in Science

Leave a Comment

JUDAH

Welcome to Judah , We`re dedicated to providing you the very best of service and products. We hop you enjoy our service and our products as much as we enjoy offering them. Donations

Explore

Subscribe



©Copyright 2021 by JUDAH

Thanks for visiting get comfortable with the space, consider donating all donations big or small entitle you to a free gift with free shipping.